By Stephen Nakrosis
SOPHiA GENETICS SA on Thursday said it was pricing its 13-million-share initial public offering at $18 per share.
The company said its stock is expected to begin trading on the Nasdaq Global Select Market on July 23 under the symbol "SOPH."
Earlier this month, the company said it expected its IPO to price between $17 and $19 per share.
J.P. Morgan, Morgan Stanley, Cowen and Credit Suisse are listed as the offering's joint book-running managers.
SOPHiA GENETICS said it created the SOPHiA DDM platform, "a global data pooling and knowledge sharing platform that advances data-driven medicine."
-Write to Stephen Nakrosis at [email protected]